AnheuserBusch InBev Shares Dip After Q4 Sales Miss Estimates Rapport Therapeutics RAPP Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Mercury Valuation Surges to 52 Billion as Fintech Resilience Persists